An LXR Agonist Promotes Glioblastoma Cell Death through Inhibition of an EGFR/AKT/SREBP-1/LDLR-Dependent Pathway Article

cited authors

  • Guo, Deliang; Reinitz, Felicia; Youssef, Mary; Hong, Cynthia; Nathanson, David; Akhavan, David; Kuga, Daisuke; Amzajerdi, Ali Nael; Soto, Horacio; Zhu, Shaojun; Babic, Ivan; Tanaka, Kazuhiro; Dang, Julie; Iwanami, Akio; Gini, Beatrice; DeJesus, Jason; Lisiero, Dominique D; Huang, Tiffany T; Prins, Robert M; Wen, Patrick Y; Robins, H Ian; Prados, Michael D; DeAngelis, Lisa M; Mellinghoff, Ingo K; Mehta, Minesh P; James, C David; Chakravarti, Arnab; Cloughesy, Timothy F; Tontonoz, Peter; Mischel, Paul S

fiu authors

publication date

  • October 1, 2011

keywords

  • FATTY-ACID SYNTHASE
  • GROWTH-FACTOR RECEPTOR
  • IN-VIVO
  • KINASE INHIBITORS
  • LDL RECEPTOR
  • LIPID RAFTS
  • Life Sciences & Biomedicine
  • NUCLEAR RECEPTORS
  • PROSTATE-CANCER
  • PROTEIN-KINASE
  • Science & Technology

start page

  • 442

issue

  • 5